MedPath

Patent blue in laryngeal cancer

Recruiting
Conditions
laryngeal cancer, sentinel lymph node
Registration Number
NL-OMON27148
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

proven carcinoma of the larynx
-> 18 yrs of age
-undergo a total laryngectomy with planned neck dissection.
-informed consent

Exclusion Criteria

-partial laryngectomy
-no planned neck dissection
-hypersensitivity for patent blue

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
After ex vivo confirmation that PB injected around LC in a laryngeal surgical specimen is not spreading into tissues beyond the tumor, the detection of SLN by a technique of injecting PB via a flexible laryngoscope using a working channel has to be tested.
Secondary Outcome Measures
NameTimeMethod
We want to analyze the difference in PB spreading for detection of SLN in primary TL and salvage TL.
© Copyright 2025. All Rights Reserved by MedPath